Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2− breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2
Damodaran, S., O’Sullivan, C.C., Elkhanany, A., Anderson, I.C., Barve, M., Blau, S., Cherian, M.A., Peguero, J.A., Goetz, M.P., Plourde, P.V., Portman, D.J., Moore, H.C.F.
Published in Annals of oncology (01.12.2023)
Published in Annals of oncology (01.12.2023)
Get full text
Journal Article
A phase I/II and pharmacokinetic study of BGB324, a selective AXL inhibitor as monotherapy and in combination with erlotinib in patients with advanced non-small cell lung cancer (NSCLC)
Byers, L, Gerber, D, Peguero, J, Micklem, D, Yule, M, Lorens, J.B
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A
Catenacci, D.V.T., Kang, Y.-K., Yoon, H.H., Shim, B.Y., Kim, S.T., Oh, D.-Y., Spira, A.I., Ulahannan, S.V., Avery, E.J., Boland, P.M., Chao, J., Chung, H.C., Gardner, F., Klempner, S.J., Lee, K.-W., Oh, S.C., Peguero, J., Sonbol, M.B., Shen, L., Moehler, M., Sun, J., Li, D., Rosales, M.K., Park, H.
Published in ESMO open (01.10.2022)
Published in ESMO open (01.10.2022)
Get full text
Journal Article
Effect of infant surgical orthopedic treatment on facial growth in preadolescent children with unilateral and bilateral complete cleft lip and palate
Tan, Stephan P.K., DDS, MPH, Allareddy, Veerasathpurush, BDS, PhD, Bruun, Richard A., DDS, Mulliken, John B., MD, Sullivan, Stephen R., MD, MPH, Peguero, Oscar J., DMD, Cooper, Justin S., DMD, MSD, Padwa, Bonnie L., DMD, MD, Gerlein, Eduardo J., DDS, MS, MMSc, Cook, E. Francis, ScD, Shusterman, Stephen, DMD
Published in Oral surgery, oral medicine, oral pathology and oral radiology (01.09.2015)
Published in Oral surgery, oral medicine, oral pathology and oral radiology (01.09.2015)
Get full text
Journal Article
Seismic Behavior of Medium and High Strength Concrete Buildings
Bairán, J.M., Moreno-González, R., Peguero, J.
Published in The open civil engineering journal (28.05.2015)
Published in The open civil engineering journal (28.05.2015)
Get full text
Journal Article
Publication
The Application of Leaf Ultrasonic Resonance to Vitis vinifera L. Suggests the Existence of a Diurnal Osmotic Adjustment Subjected to Photosynthesis
Sancho-Knapik, Domingo, Medrano, Hipólito, Peguero-Pina, José J, Mencuccini, Maurizio, Fariñas, Maria D, Álvarez-Arenas, Tomás G, Gil-Pelegrín, Eustaquio
Published in Frontiers in plant science (26.10.2016)
Published in Frontiers in plant science (26.10.2016)
Get full text
Journal Article
Corrigendum to ‘Mesophyll diffusion conductance to CO2: An unappreciated central player in photosynthesis’ [Plant Sci. 193–194 (2012) 70–84]
Flexas, Jaume, Barbour, Margaret M., Brendel, Oliver, Cabrera, Hernán M., Carriquí, Marc, Díaz-Espejo, Antonio, Douthe, Cyril, Dreyerc, Erwin, Ferrio, Juan P., Gago, Jorge, Gallé, Alexander, Galmés, Jeroni, Kodama, Naomi, Medrano, Hipólito, Niinemets, Ülo, Peguero-Pina, José J., Pou, Alicia, Ribas-Carbó, Miquel, Tomás, Magdalena, Tosens, Tiina, Warren, Charles R.
Published in Plant science (Limerick) (01.11.2012)
Published in Plant science (Limerick) (01.11.2012)
Get full text
Journal Article
324P Effect of NALIRIFOX in Asian patients (pts) with treatment-naive metastatic pancreatic adenocarcinoma (mPAC): Results from the NAPOLI 3 trial
Lee, W., Kim, I-H., Oh, S.C., Lomma, C., Macarulla Mercade, T., Zervoudakis, A., Vicuna, B., Sampat, K., Bullock, A., Segelov, E., Paulson, A.S., Peguero, J., Hassan, H., Delaporte, F., Martin Fernandez, L., Causse-Amellal, N., Melisi, D.
Published in Annals of oncology (01.06.2024)
Published in Annals of oncology (01.06.2024)
Get full text
Journal Article
11MO Final data from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3) and pembrolizumab in 2nd-line metastatic NSCLC pts resistant to PD-1/PD-L1 inhibitors
Majem, M., Forster, M.D., Krebs, M.G., Peguero, J., Clay, T.D., Felip, E., Iams, W., Roxburgh, P., de Spéville, B. Doger, Bajaj, P., Mueller, C., Triebel, F.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
1266P Initial results from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in patients with PD-L1 unselected first-line metastatic non-small cell lung carcinoma
Majem, M., Felip, E., Doger, B., Akay, M., Carcereny, E., Clay, T., Krebs, M.G., Peguero, J., Triebel, F.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors
Barlesi, Fabrice, Isambert, Nicolas, Felip, Enriqueta, Cho, Byoung Chul, Lee, Dae Ho, Peguero, Julio, Jerusalem, Guy, Penel, Nicolas, Saada-Bouzid, Esma, Garrido, Pilar, Helwig, Christoph, Locke, George, Ojalvo, Laureen S, Gulley, James L
Published in The oncologist (Dayton, Ohio) (17.03.2023)
Published in The oncologist (Dayton, Ohio) (17.03.2023)
Get full text
Journal Article
Web Resource
1312MO Combining the antigen-presenting cell activator eftilagimod alpha (soluble LAG-3) and pembrolizumab: Overall survival data from the first line non-small cell lung carcinoma (NSCLC) cohort of TACTI-002 (phase II)
Carcereny, E., Felip, E., Majem, M., Doger de Spéville, B., Clay, T.D., Bondarenko, I., Peguero, J., Cobo Dols, M., Forster, M.D., Ursol, G., Kalinka, E., Garcia Ledo, G.M., Vila Martinez, L., Iams, W., Krebs, M.G., Kefas, J., Efthymiadis, K., Perera, S., Mueller, C., Triebel, F.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
927P Initial results from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab as 2nd line treatment for PD-L1 unselected metastatic head and neck cancer patients
Forster, M., Felip, E., Doger, B., Lopez Pousa, A., Carcereny, E., Bajaj, P., Church, M., Peguero, J., Roxburgh, P., Triebel, F.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
Hartmaier, R.J., Trabucco, S.E., Priedigkeit, N., Chung, J.H., Parachoniak, C.A., Vanden Borre, P., Morley, S., Rosenzweig, M., Gay, L.M., Goldberg, M.E., Suh, J., Ali, S.M., Ross, J., Leyland-Jones, B., Young, B., Williams, C., Park, B., Tsai, M., Haley, B., Peguero, J., Callahan, R.D., Sachelarie, I., Cho, J., Atkinson, J.M., Bahreini, A., Nagle, A.M., Puhalla, S.L., Watters, R.J., Erdogan-Yildirim, Z., Cao, L., Oesterreich, S., Mathew, A., Lucas, P.C., Davidson, N.E., Brufsky, A.M., Frampton, G.M., Stephens, P.J., Chmielecki, J., Lee, A.V.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
EP08.01-109 TACTI-002: A Phase II Study of Eftilagimod Alpha (Soluble LAG-3) & Pembrolizumab in 2nd line PD-1/PD-L1 Refractory Metastatic NSCLC
Forster, M., Krebs, M., Majem, M., Peguero, J., Clay, T., Felip, E., Iams, W., Roxburgh, P., Doger, B., Bajaj, P., Kefas, J., Scott, J.-.A., Barba Joaquín, A., Mueller, C., Triebel, F.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
Cambios en el perfil terpénico y en el crecimiento secundario en poblaciones en decaimiento de Pinus sylvestris L. bajo influencia mediterránea en respuesta a factores locales
M. A. Sanz, J. Sánchez, J. J. Camarero, J. J. Peguero-Pina, D. Sancho-Knapik, E. Gil-Pelegrín
Published in Pirineos (01.12.2014)
Published in Pirineos (01.12.2014)
Get full text
Journal Article